T. Rowe Price Associates’s Kiniksa Pharmaceuticals KNSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,755
| Closed | -$373K | – | 3103 |
|
|
2025
Q1 | $373K | Buy |
16,755
+1,644
| +11% | +$36.6K | ﹤0.01% | 2373 |
|
|
2024
Q4 | $299K | Buy |
15,111
+2,881
| +24% | +$57K | ﹤0.01% | 2504 |
|
|
2024
Q3 | $306K | Buy |
12,230
+348
| +3% | +$8.71K | ﹤0.01% | 2466 |
|
|
2024
Q2 | $222K | Buy |
+11,882
| New | +$222K | ﹤0.01% | 2553 |
|
|
2021
Q3 | – | Sell |
-13,231
| Closed | -$184K | – | 2958 |
|
|
2021
Q2 | $184K | Buy |
+13,231
| New | +$184K | ﹤0.01% | 2742 |
|